MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,109,000 | -36.4% | 51,561 | -51.5% | 3.00% | -20.6% |
| Q1 2016 | $4,890,000 | +10.8% | 106,358 | +16.5% | 3.78% | +29.6% |
| Q4 2015 | $4,414,000 | -12.3% | 91,310 | -22.9% | 2.92% | +5.0% |
| Q3 2015 | $5,031,000 | +28.3% | 118,372 | +244.7% | 2.78% | -10.6% |
| Q2 2015 | $3,922,000 | -1.2% | 34,344 | +11.7% | 3.11% | -6.6% |
| Q1 2015 | $3,969,000 | +27.0% | 30,747 | -2.0% | 3.33% | +7.6% |
| Q4 2014 | $3,125,000 | – | 31,377 | – | 3.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |